Zemin Zhang

A renowned professor in cancer genomics and bioinformatics, Dr. Zhang is currently an Associate Director at BIOPIC College of Life Sciences, Peking University, and Senior Principal Investigator, Peking-Tsinghua University Center of Life Sciences. His current research focuses on using cutting-edge technologies such as single-cell sequencing to understand oncogenesis and cancer immunology. Previously, he spent more than 16 years at Genentech/Roche, leading the cancer genomics and bioinformatics group to discover anticancer targets and biomarkers using new technologies such as machine learning and high-throughput sequencing. An inventor with more than 60 issued US patents, Dr. Zhang has pioneered multiple research directions in computational cancer biology and cancer genomics including the first-ever whole genome tumor sequencing, and has directly contributed to the initial finding of the molecular targets of multiple cancer therapeutic agents in clinical trials. He is on the editorial boards for journals including Cell Systems, Genome Medicine, and Cancer Informatics. He is a CUSBEA Scholar and also a Cheung Kong Scholar. Dr. Zhang received his bachelor’s degree in Genetics from Nankai University, and a Ph.D. in Biochemistry and Molecular Biology from Penn State University. He received additional training in Information Technology from UC Berkeley and conducted postdoctoral training in Laboratory Medicine from UC San Francisco.